Analysts’ Viewpoint on Life Science Instrumentation Market Scenario
Increase in R&D spending by leading players, rise in prevalence and incidence rate of infectious diseases, and technological developments are projected to drive the global life science instrumentation market during the forecast period. Companies operating in the market are increasingly investing in research and development activities in life sciences. Several companies are also engaged in mergers and acquisitions, joint ventures, partnerships, and collaborations to maintain their position in the global life science instrumentation market. Government bodies across the world are focusing on research operations to discover treatments for severe infections and rare diseases such as COVID-19. This is expected to drive the global life science instrumentation market during the forecast period.
Usage of various methods such as chromatography, spectroscopy, next-generation sequencing, polymerase chain reaction, flow cytometry, immunoassays, and clinical chemistry analyzers has increased significantly. This has led to a rise in demand for life science and chemical instrumentation in the global market, thus boosting the life science and chemical instrumentation market. Companies in the global life science instrumentation market are emphasizing on the release of innovative, cutting-edge products. This is likely to augment the global life science instrumentation market size in the near future.
Life science laboratory equipment is primarily used for the diagnosis of infectious and chronic diseases. The advent and breakout of several infectious diseases have presented obstacles as well as new possibilities for researchers working on diagnostic tools and tests for advanced disease detection and prevention. According to the WHO's World Health Report, infectious diseases account for around 17 million deaths globally each year. Furthermore, the emergence of new diseases has increased in the last few years, as a number of countries have reportedly not made enough investment in R&D to combat prevalent infectious diseases. The need for diagnostic technologies for the early diagnosis of infectious diseases to prevent outbreaks is rising. This is anticipated to propel the global life science instrumentation market.
Industries such as biotechnology and pharmaceuticals are investing significantly in R&D. This can be ascribed to the rise in need for quick medication development and innovative drug molecule commercialization for the treatment of uncommon illnesses. According to the International Federation of Pharmaceutical Manufacturers and Association (IFPMA), the pharmaceutical industry spends around US$ 150 Bn on research and development annually. More than 7,000 novel compounds were developed, while 56 new medications were introduced in 2015. Rapid and effective life science instrumentation devices are required to accelerate the drug development process. Rise in R&D in drug development for conditions such as cardiovascular illnesses, neurological disorders, cancer, and infectious diseases is expected to drive the global life science instrumentation market.
In terms of technique, the life science instrumentation market has been classified into spectroscopy, chromatography, polymerase chain reaction, next-generation sequencing, clinical chemistry analyzers, flow cytometry, immunoassays, and others (incubator, electrophoresis, etc.). The spectroscopy segment dominated the global life science instrumentation market in 2021. Spectroscopy is essential in domains relating to bio- and life sciences for detection, identification, and quantification of molecules. The spectroscopy segment is anticipated to be driven by ongoing improvements in spectroscopic technology and rise in demand for real-time sample analysis.
Based on application, the global market has been divided into research applications, laboratory applications, and others. Research applications is expected to be a highly attractive segment of the global life science instrumentation market during the forecast period. This can be ascribed to the mounting pressure on the pharmaceutical industry to create novel, affordable treatments for different ailments. Surge in drug discovery activities is also projected to drive the demand for life science lab instruments. Rise in innovative medications & treatments under development is likely to augment the research applications segment during the forecast period.
In terms of end-user, the global life science instrumentation market has been classified into research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and others. The pharmaceutical & biotechnology companies segment held the major share of the global market in 2021. The segment is projected to sustain its market share during the forecast period due to the increase in usage of life science and chemical instrumentation in drug manufacturing processes to maintain the quality of drugs.
North America dominated the global life science instrumentation market in 2021. It is projected to maintain its share during the forecast period. This can be ascribed to a large patient pool, technological advancements, and high acceptance of advanced treatments in the region. Increase in health care expenditure, rise in prevalence & incidence of chronic infectious diseases, and surge in investments are also anticipated to propel the life science instrumentation market in North America in the next few years.
Europe accounted for the second largest share of the global market in 2021. High prevalence of chronic diseases such as diabetes, cancer, kidney disease, and inflammatory bowel disease; increase in geriatric population requiring regular medical tests; and well-established health care infrastructure are the major factors contributing to the region’s large share of the global life science instrumentation market.
The life science instrumentation market in Asia Pacific is expected to grow at a high CAGR during the forecast period due to the increase in demand for efficient and high-speed diagnostic equipment in developing countries; and rise in research initiatives in countries such as Japan and China.
The global life science instrumentation market comprises several small and large-scale companies that control majority of the share. Mergers and acquisitions and development of product portfolios, product launches, product approvals, and agreements are major strategies implemented by several key players. Prominent players operating in the global life science instrumentation market are Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer, Inc., BD, Bruker, and Hitachi High-Tech Corporation.
Each of these players has been profiled in the life science instrumentation market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Attribute |
Detail |
Market Size Value in 2021 |
US$ 56.6 Bn |
Market Forecast Value in 2031 |
More than US$ 104.5 Bn |
Growth Rate (CAGR) 2022-2031 |
6.3% |
Forecast Period |
2022–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Bn for Value |
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global life science instrumentation market was valued at US$ 56.6 Bn in 2021
The global life science instrumentation market is projected to reach more than US$ 104.5 Bn by 2031
The global life science instrumentation market grew at a CAGR of 5.3% from 2017 to 2021
The global life science instrumentation market is anticipated to grow at a CAGR of 6.3% from 2022 to 2031
The research applications segment held major share of around 42% of the global life science instrumentation market in 2021
North America is expected to account for major share of the global life science instrumentation market during the forecast period
Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer, Inc., BD, Bruker, and Hitachi High-Tech Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Life Science Instrumentation Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Life Science Instrumentation Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Reimbursement Scenario, by Region/globally
5.2. Key Mergers & Acquisitions
5.3. Technological Advancement
6. Global Life Science Instrumentation Market Analysis and Forecast, by Technique
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Technique, 2017–2031
6.3.1. Spectroscopy
6.3.2. Chromatography
6.3.3. Polymerase Chain Reaction
6.3.4. Next-generation Sequencing
6.3.5. Clinical Chemistry Analyzers
6.3.6. Flow Cytometry
6.3.7. Immunoassays
6.3.8. Others
6.4. Market Attractiveness Analysis, by Technique
7. Global Life Science Instrumentation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Research Applications
7.3.2. Clinical Applications
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Life Science Instrumentation Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Research Institutes
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Diagnostic Laboratories
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Life Science Instrumentation Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Life Science Instrumentation Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technique, 2017–2031
10.2.1. Spectroscopy
10.2.2. Chromatography
10.2.3. Polymerase Chain Reaction
10.2.4. Next-generation Sequencing
10.2.5. Clinical Chemistry Analyzers
10.2.6. Flow Cytometry
10.2.7. Immunoassays
10.2.8. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Research Applications
10.3.2. Clinical Applications
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Research Institutes
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Diagnostic Laboratories
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technique
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Life Science Instrumentation Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technique, 2017–2031
11.2.1. Spectroscopy
11.2.2. Chromatography
11.2.3. Polymerase Chain Reaction
11.2.4. Next-generation Sequencing
11.2.5. Clinical Chemistry Analyzers
11.2.6. Flow Cytometry
11.2.7. Immunoassays
11.2.8. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Research Applications
11.3.2. Clinical Applications
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Research Institutes
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Diagnostic Laboratories
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technique
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Life Science Instrumentation Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technique, 2017–2031
12.2.1. Chromatography
12.2.2. Polymerase Chain Reaction
12.2.3. Next-generation Sequencing
12.2.4. Clinical Chemistry Analyzers
12.2.5. Flow Cytometry
12.2.6. Immunoassays
12.2.7. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Research Applications
12.3.2. Clinical Applications
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Research Institutes
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Diagnostic Laboratories
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technique
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Life Science Instrumentation Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technique, 2017–2031
13.2.1. Spectroscopy
13.2.2. Chromatography
13.2.3. Polymerase Chain Reaction
13.2.4. Next-generation Sequencing
13.2.5. Clinical Chemistry Analyzers
13.2.6. Flow Cytometry
13.2.7. Immunoassays
13.2.8. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Research Applications
13.3.2. Clinical Applications
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Research Institutes
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Diagnostic Laboratories
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technique
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Life Science Instrumentation Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technique, 2017–2031
14.2.1. Spectroscopy
14.2.2. Chromatography
14.2.3. Polymerase Chain Reaction
14.2.4. Next-generation Sequencing
14.2.5. Clinical Chemistry Analyzers
14.2.6. Flow Cytometry
14.2.7. Immunoassays
14.2.8. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Research Applications
14.3.2. Clinical Applications
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Research Institutes
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Diagnostic Laboratories
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technique
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. Danaher
15.1.1.1. Company Overview
15.1.1.2. Product Portfolio
15.1.1.3. SWOT Analysis
15.1.1.4. Financial Overview
15.1.1.5. Strategic Overview
15.1.2. Thermo Fisher Scientific, Inc.
15.1.2.1. Company Overview
15.1.2.2. Product Portfolio
15.1.2.3. SWOT Analysis
15.1.2.4. Financial Overview
15.1.2.5. Strategic Overview
15.1.3. Merck KGaA
15.1.3.1. Company Overview
15.1.3.2. Product Portfolio
15.1.3.3. SWOT Analysis
15.1.3.4. Financial Overview
15.1.3.5. Strategic Overview
15.1.4. Bio-Rad Laboratories, Inc.
15.1.4.1. Company Overview
15.1.4.2. Product Portfolio
15.1.4.3. SWOT Analysis
15.1.4.4. Financial Overview
15.1.4.5. Strategic Overview
15.1.5. Agilent Technologies, Inc.
15.1.5.1. Company Overview
15.1.5.2. Product Portfolio
15.1.5.3. SWOT Analysis
15.1.5.4. Financial Overview
15.1.5.5. Strategic Overview
15.1.6. Illumina, Inc.
15.1.6.1. Company Overview
15.1.6.2. Product Portfolio
15.1.6.3. SWOT Analysis
15.1.6.4. Financial Overview
15.1.6.5. Strategic Overview
15.1.7. PerkinElmer, Inc.
15.1.7.1. Company Overview
15.1.7.2. Product Portfolio
15.1.7.3. SWOT Analysis
15.1.7.4. Financial Overview
15.1.7.5. Strategic Overview
15.1.8. BD
15.1.8.1. Company Overview
15.1.8.2. Product Portfolio
15.1.8.3. SWOT Analysis
15.1.8.4. Financial Overview
15.1.8.5. Strategic Overview
15.1.9. Bruker
15.1.9.1. Company Overview
15.1.9.2. Product Portfolio
15.1.9.3. SWOT Analysis
15.1.9.4. Financial Overview
15.1.9.5. Strategic Overview
15.1.10. Hitachi High-Technologies Corporation
15.1.10.1. Company Overview
15.1.10.2. Product Portfolio
15.1.10.3. SWOT Analysis
15.1.10.4. Financial Overview
15.1.10.5. Strategic Overview
List of Tables
Table 01: Global Life Science Instrumentation Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 02: Global Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Life Science Instrumentation Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 07: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: U.S. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: U.S. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 11: U.S. Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Canada Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 13: Canada Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 14: Canada Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 17: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Germany Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 20: Germany Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 21: Germany Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 22: U.K. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 23: U.K. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: U.K. Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: France Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 26: France Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 27: France Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 28: Italy Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 29: Italy Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Italy Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Spain Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 32: Spain Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 33: Spain Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 34: Rest of Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 35: Rest of Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 36: Rest of Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 37: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 38: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 39: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 40: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Japan Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 42: Japan Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 43: Japan Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 44: China Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 45: China Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 46: China Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 47: India Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 48: India Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 49: India Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 50: Australia & New Zealand Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 51: Australia & New Zealand Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 52: Australia & New Zealand Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 53: Rest of Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 54: Rest of Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 55: Rest of Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 56: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 57: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 58: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 59: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 60: Brazil Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 61: Brazil Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 62: Brazil Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 63: Mexico Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 64: Mexico Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 65: Mexico Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 66: Rest of Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 67: Rest of Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 68: Rest of Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 69: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 70: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 71: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 72: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 73: GCC Countries Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 74: GCC Countries Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 75: GCC Countries Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 76: South Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 77: South Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 78: South Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 79: Rest of Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 80: Rest of Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 81: Rest of Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Life Science Instrumentation Market Size (US$ Mn) and Distribution, by Region, 2022 and 2031
Figure 02: Market Snapshot of Global Life Science Instrumentation Market
Figure 03: Market Opportunity Map, Revenue Share, by Technique
Figure 04: Market Opportunity Map, Revenue Share, by Application
Figure 05: Market Opportunity Map, Revenue Share, by End-user
Figure 06: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 07: Global Life Science Instrumentation Market Value Share, by Technique, 2021
Figure 08: Global Life Science Instrumentation Market Value Share, by Application, 2021
Figure 09: Global Life Science Instrumentation Market Value Share, by End-user, 2021
Figure 10: Global Life Science Instrumentation Market Value Share, by Region, 2021
Figure 11: Global Life Science Instrumentation Market Value Share Analysis, by Technique, 2022 and 2031
Figure 12: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Spectroscopy, 2017–2031
Figure 13: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Chromatography, 2017–2031
Figure 14: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Polymerase Chain Reaction, 2017–2031
Figure 15: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Next-generation Sequencing, 2017–2031
Figure 16: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Chemistry Analyzers, 2017–2031
Figure 17: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Flow Cytometry, 2017–2031
Figure 18: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Immunoassays, 2017–2031
Figure 19: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2031
Figure 20: Global Life Science Instrumentation Market Attractiveness Analysis, by Technique, 2021 and 2031
Figure 21: Global Life Science Instrumentation Market Value Share Analysis, by Application, 2022 and 2031
Figure 22: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Research Applications, 2017–2031
Figure 23: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Applications, 2017–2031
Figure 24: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2031
Figure 25: Global Life Science Instrumentation Market Attractiveness Analysis, by Application, 2021–2027
Figure 26: Global Life Science Instrumentation Market Value Share Analysis, by End-user, 2022 and 2031
Figure 27: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Research Institutes, 2017–2031
Figure 28: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 29: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic Laboratories, 2017–2031
Figure 30: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2031
Figure 31: Global Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 32: Global Life Science Instrumentation Market Value Share (%), by Region, 2022 and 2031
Figure 33: Global Life Science Instrumentation Market Attractiveness Analysis, by Region, 2021–2031
Figure 34: North America Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 35: North America Life Science Instrumentation Market Value Share, by Country, 2022 and 2031
Figure 36: North America Life Science Instrumentation Market Attractiveness Analysis, by Country, 2021–2031
Figure 37: North America Life Science Instrumentation Market Value Share, by Technique, 2022 and 2031
Figure 38: North America Life Science Instrumentation Market Attractiveness Analysis, by Technique, 2021–2031
Figure 39: North America Life Science Instrumentation Market Value Share, by Application, 2022 and 2031
Figure 40: North America Life Science Instrumentation Market Attractiveness Analysis, by Application, 2021–2031
Figure 41: North America Life Science Instrumentation Market Value Share, by End-user, 2022 and 2031
Figure 42: North America Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 43: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 44: Europe Life Science Instrumentation Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 45: Europe Life Science Instrumentation Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 46: Europe Life Science Instrumentation Market Value Share, by Technique, 2022 and 2031
Figure 47: Europe Life Science Instrumentation Market Attractiveness Analysis, by Technique, 2021–2031
Figure 48: Europe Life Science Instrumentation Market Value Share, by Application, 2022 and 2031
Figure 49: Europe Life Science Instrumentation Market Attractiveness Analysis, by Application, 2021–2031
Figure 50: Europe Life Science Instrumentation Market Value Share, by End-user, 2022 and 2031
Figure 51: Europe Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 52: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 53: Asia Pacific Life Science Instrumentation Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 54: Asia Pacific Life Science Instrumentation Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 55: Asia Pacific Life Science Instrumentation Market Value Share, by Technique, 2022 and 2031
Figure 56: Asia Pacific Life Science Instrumentation Market Attractiveness Analysis, by Technique, 2021–2031
Figure 57: Asia Pacific Life Science Instrumentation Market Value Share, by Application, 2022 and 2031
Figure 58: Asia Pacific Life Science Instrumentation Market Attractiveness Analysis, by Application, 2021–2031
Figure 59: Asia Pacific Life Science Instrumentation Market Value Share, by End-user, 2022 and 2031
Figure 60: Asia Pacific Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2021–2031
Figure 61: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 62: Latin America Life Science Instrumentation Market Attractiveness Analysis, by Country/Sub-region, 2021 and 2031
Figure 63: Latin America Life Science Instrumentation Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 64: Latin America Life Science Instrumentation Market Value Share, by Technique, 2022 and 2031
Figure 65: Latin America Life Science Instrumentation Market Attractiveness Analysis, by Technique, 2021 and 2031
Figure 66: Latin America Life Science Instrumentation Market Value Share, by Application, 2022 and 2031
Figure 67: Latin America Life Science Instrumentation Market Attractiveness Analysis, by Application, 2021 and 2031
Figure 68: Latin America Life Science Instrumentation Market Value Share, by End-user, 2022 and 2031
Figure 69: Latin America Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2021 and 2031
Figure 70: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2031
Figure 71: Middle East & Africa Life Science Instrumentation Market Attractiveness Analysis, by Country/Sub-region, 2021 and 2031
Figure 72: Middle East & Africa Life Science Instrumentation Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 73: Middle East & Africa Life Science Instrumentation Market Value Share, by Technique, 2022 and 2031
Figure 74: Middle East & Africa Life Science Instrumentation Market Attractiveness Analysis, by Technique, 2021 and 2031
Figure 75: Middle East & Africa Life Science Instrumentation Market Value Share, by Application, 2022 and 2031
Figure 76: Middle East & Africa Life Science Instrumentation Market Attractiveness Analysis, by Application, 2021 and 2031
Figure 77: Middle East & Africa Life Science Instrumentation Market Value Share, by End-user, 2022 and 2031
Figure 78: Middle East & Africa Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2021 and 2031